Viracta Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $872k | 1.5M | 0.57 |
| 2023-09-30 | $1.6M | 1.5M | 1.04 |
| 2023-06-30 | $2.2M | 1.5M | 1.41 |
| 2023-03-31 | $2.5M | 1.6M | 1.59 |
| 2022-12-31 | $2.3M | 1.6M | 1.46 |
| 2022-06-30 | $6.5M | 1.7M | 3.88 |
| 2022-03-31 | $8.1M | 1.7M | 4.76 |
| 2021-12-31 | $5.8M | 1.6M | 3.69 |
| 2021-09-30 | $13M | 1.6M | 8.00 |
| 2021-06-30 | $18M | 1.6M | 11.34 |
| 2021-03-31 | $15M | 1.6M | 9.25 |